Divi's Laboratories declines despite reporting 21% rise in consolidated net profit in Q1
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Divi's Laboratories is currently trading at Rs. 4831.00, down by 159.35 points or 3.19% from its previous closing of Rs. 4990.35 on the BSE.
The scrip opened at Rs. 4987.95 and has touched a high and low of Rs. 4987.95 and Rs. 4777.30 respectively. So far 12756 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 5011.00 on 02-Aug-2024 and a 52 week low of Rs. 3300.00 on 06-Nov-2023.
Last one week high and low of the scrip stood at Rs. 5011.00 and Rs. 4770.25 respectively. The current market cap of the company is Rs. 127775.34 crore.
The promoters holding in the company stood at 51.90%, while Institutions and Non-Institutions held 37.93% and 10.18% respectively.
Divi's Laboratories has reported 24.63% rise in net profit at Rs 430 crore or first quarter ended June 30, 2024 as compared to Rs 345 crore for the same quarter in the previous year. Total income of the company increased by 18.34% at Rs 2142 crore for Q1FY25 as compared to Rs 1810 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 20.78% rise in its net profit at Rs 430 crore for the quarter ended June 30, 2024 as compared to Rs 356 crore for the same quarter in the previous year. Total income of the company increased by 18.18% at Rs 2197 crore for Q1FY25 as compared to Rs 1859 crore for the corresponding quarter previous year.
.jpg)
